2008 - Antihypertensive therapy with indapamide and perindopril reduced mortality in patients greater than or equal to 80 years
- Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. // Current Medical Literature: Cardiology;2010, Vol. 29 Issue 4, p106
The article evaluates the potential of high blood pressure treatments for patients aged 80 years and above, based on a published study in the 2010 edition of "Journal of Hypertension." The study evaluated data of patients from various clinical tests including the Systolic Hypertension in the...
- Comorbidities in the Aging Breast Cancer Population: Are Current Assessments Leading to Improved Outcomes? McCaskill-Stevens, Worta; Abrams, Jeffrey S. // JNCI: Journal of the National Cancer Institute;Jul2011, Vol. 103 Issue 14, p1072
In this article the author reflects on the mortality and survival rates among aging breast cancer patients in the U.S. in the 65 years or older age range. He cites the study by Patnaik and colleagues published in this issue on the effect of some comorbid conditions on the mortality and overall...
- Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study. Derk, Chris T.; Artlett, Carol M.; Jimenez, Sergio A. // Clinical Rheumatology;Dec2006, Vol. 25 Issue 6, p831
This study aims to characterize the clinical features of a cohort of patients diagnosed with systemic sclerosis (SSc) after the age of 75 and compare them to a group diagnosed at a younger age. We record the review of 769 patients diagnosed with SSc over the past 16 years. Utilizing a nested...
- DOES MEDICARE SAVE LIVES? Card, David; Dobkin, Carlos; Maestas, Nicole // Quarterly Journal of Economics;May2009, Vol. 124 Issue 2, p597
Health insurance characteristics shift at age 65 as most people become eligible for Medicare. We measure the impacts of these changes on patients who are admitted to hospitals through emergency departments for conditions with similar admission rates on weekdays and weekends. The age profiles of...
- Plasma Total Testosterone and Incident Cardiovascular Events in Hypertensive Patients. Vlachopoulos, Charalambos; Ioakeimidis, Nikolaos; Terentes-Printzios, Dimitrios; Aznaouridis, Konstantinos; Rokkas, Konstantinos; Aggelis, Athanassios; Synodinos, Alexandros; Lazaros, George; Stefanadis, Christodoulos // American Journal of Hypertension;Mar2013, Vol. 26 Issue 3, p373
BACKGROUND Androgen deficiency confers an independent risk for cardiovascular events and total mortality. Hypertension, a major contributory factor to the development of cardiovascular disease, has also been associated with increased prevalence of low testosterone. We investigated whether low...
- STUDY: FALLS NOT A MAJOR RISK FOR SENIORS ON ANTIHYPERTENSIVE DRUGS. // Heart Advisor;Jul2015, Vol. 18 Issue 7, p2
The article discusses the study published in the "Hypertension" journal which revealed that older adults taking antihypertensive drugs are not at major risk of falls, suggesting that patients and physicians must collaborate to ensure that effective antihypertensive doses are administered.
- Geriatric Index of Comorbidity: validation and comparison with other measures of comorbidity. Rozzini, Renzo; Frisoni, Giovanni B.; Ferrucci, Luigi; Barbisoni, Piera; Sabatini, Toni; Ranieri, Piera; Guralnik, Jack M.; Trabucchi, Marco // Age & Ageing;Jul2002, Vol. 31 Issue 4, p277
Presents a study which compared the concurrent validity of a number of measures of chronic comorbidity in elderly patients. Methodology; Results; Discussion.
- Comorbidity of Five Chronic Health Conditions in Elderly Community Residents: Determinants and Impact on Mortality. Fillenbaum, Gerda G.; Pieper, Carl F. // Journals of Gerontology Series A: Biological Sciences & Medical ;Feb2000, Vol. 55A Issue 2, pM84
Presents a study which dealt with assessing comorbidity in elderly persons and its correlation and impact in representative community residents. Methodology; Results of the study; Discussion.
- Developments in early-stage NSCLC: advances in radiotherapy. Verstegen, N. E.; Lagerwaard, F. J.; Senan, S. // Annals of Oncology;Sep2012 Supplement 10, Vol. 23 Issue suppl_10, px46
An increase in the number of predominantly elderly patients with early-stage non-small-cell lung cancer is anticipated in many Western populations. Patients often have major co-morbidities and are at increased risk for surgical morbidity and mortality. In the past decade, the use of stereotactic...